Additional Listing

Azure Holdings PLC 03 October 2006 Azure Holdings plc (the 'Company') First Day of Dealings on AIM Following the approval of the special resolutions at the Extraordinary General Meeting ('EGM') and Class Meetings held yesterday, the Company announces the admission, in aggregate, of 885,191,389 ordinary shares of 0.2p each ('Ordinary Shares') to trading on AIM today. At the EGM, Barry Gold resigned as a director of the Company. Anthony Moore was appointed Non-executive Chairman; Dr Satu Vainikka was appointed Chief Executive; Dr Jacob Micallef was appointed Chief Operating Officer; Dr George Morris was appointed Chief Development Officer and Kevin Alexander was appointed as a Non-executive Director of the Company. Gerald Desler remains as Finance Director. The Company's name is expected to change to ValiRx plc effective from 4 October 2006. Anthony Moore, Non-executive Chairman, ValiRx plc, commented: 'I am delighted that the reverse transaction into Azure Holdings plc has completed and the enlarged group is quoted on AIM. I believe that the Company has some exciting products and I look forward to their development and anticipate regular positive newsflow.' For further information, please contact: ValiRx plc Anthony Moore Dr Satu Vainikka Tel: 0207 408 5400 WH Ireland Limited David Youngman Tel: 0161 832 2174 This information is provided by RNS The company news service from the London Stock Exchange

Companies

Valirx (VAL)
UK 100